HOT NEWS
European Commission Issues Positive Decision for Approval of Seroquel XR » AstraZeneca announced that the European Commission (EC) has issued a positive decision for the appro...
Data from Mipomersen Phase 3 Trial in heFH Patients Presented at ESC » Genzyme Corp. (NASDAQ: GENZ) and Isis Pharmaceuticals Inc. (NASDAQ: ISIS) announced that data from t...
Global market launch of Daxas® (Roflumilast) kicks off in Germany » Stefan Brinkmann, Managing Director of Nycomed GmbH, kicked off the German market launch of Daxas® ...
A new era for patients with atrial fibrillation - Dabigatran etexilate at the fo... » The European Society of Cardiology (ESC) issued revised practice guidelines for the management of at...
Genetic substudy shows fewer major cardiovascular events with ticagrelor (BRILIN... » A new genetic substudy of PLATO (A Study of PLATelet Inhibition and Patient Outcomes) showed that th...
Shire Announces European Approval of VPRIV® (velaglucerase alfa) » Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announced today...
Bristol-Myers Squibb and Pfizer Inc Evaluate Unmet Need in Patients with Atrial ... » Bristol-Myers Squibb Company (NYSE: BMY) and Pfizer (NYSE: PFE) report that preliminary results from...
GSK European Commission amends licence for Cervarix® » GlaxoSmithKline (GSK) confirmed that the European Commission has granted Marketing Authorisation to ...
Amgen Announces Top-Line Results of Phase 3 Head and Neck Cancer Trial » Amgen (Nasdaq: AMGN) announced top-line results from a randomized Phase 3 trial evaluating Vectibix(...
Pfizer Reports Second-Quarter 2010 Results » Pfizer Inc. (NYSE: PFE) has reported financial results for second-quarter 2010. Since the acquisitio...
Industry News

All Industry News RSS Channel
Bookmark and Share